Elanco Teams Up with Medgene to Fight Avian Flu in Dairy Cattle — Here's What It Means for U.S. Farmers!
Elanco Animal Health is making a major move in the battle against avian influenza, announcing a partnership with South Dakota-based Medgene to commercialize a highly pathogenic avian influenza (HPAI) vaccine designed for dairy cattle. This groundbreaking agreement marks a critical step in combating the spread of this devastating disease, which has affected nearly 1,000 dairy herds across the U.S. since March 2024.
Elanco Launches Supplement Line for Dogs – Here’s What You Need to Know
The pet wellness industry is in for a big shift! Elanco Animal Health has officially launched Pet Protect™, a new line of veterinarian-formulated supplements designed to address the diverse health needs of dogs. As the demand for pet supplements continues to grow, this innovative line aims to set a new standard in pet care.
FDA Approves New Treatment for Allergic Skin Conditions in Dogs
Today, the U.S. Food and Drug Administration approved Zenrelia (ilunocitinib tablets), a new animal drug used to control pruritus (itching) associated with allergic dermatitis and to control atopic dermatitis (environmental allergies) in dogs at least 1 year of age.
Purdue University and Elanco Join Forces for One Health Innovation District in Indianapolis
Purdue University partners with Elanco Animal Health to create the One Health Innovation District in Indianapolis, focusing on integrated health solutions for people, animals, and plants. This collaboration aims to drive innovation, attract top talent, and bolster regional growth.